Loading

AI/ML is Transforming R&D and Business

June 04, 2024
Breakout Session
AI and Digital Health
24BC
Artificial intelligence (AI) and machine learning (ML) are ideal "power tools” for drug discovery and development. Leaders across big pharma and emerging biotech’s with platforms grounded in AI/ML will describe how these technologies have been fundamental to their business strategy, enabling the efficiency and scale of their drug discovery and helping raise financings and drive partnerships.
Speakers
Maude Tessier, PhD
Chief Business Officer
Seismic Therapeutic
Speakers
Karen Akinsanya, PhD
President, R&D - Therapeutics
Schrodinger, Inc.
Frank Grams
Chief Commercial Officer
Partex NV
Joe McDonald
Chief Data Officer
Odyssey Therapeutics
Jiye Shi
Vice President
Eli Lilly
Back to Session List

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS